Episode Details

Back to Episodes
Cramer's Morning Take: Bristol Myers & Eli Lilly 11/25/24

Cramer's Morning Take: Bristol Myers & Eli Lilly 11/25/24

Published 1 year, 3 months ago
Description

Jim and Jeff discuss why they’re buying this biopharmaceutical stock. They also talk about adding to this pharmaceutical stock. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake 

CNBC Investing Club Disclaimer

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us